Active · per the CBE, 28 September 2026

VERGEL

BE0812259489

Rechtspersoon Private limited company 1 establishment

VERGEL is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 12 June 2009, 1 establishment.

Flandria 3, 8750 Wingene

Behind the company: Bobbie Pharmaceutical Services BV, Cécile Hoogmartens, CéVéGé BV.

Active for

17 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 49 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

VERGEL from Wingene, company number BE0812259489, closed financial year 2025 with a result of € 80,264 after tax. For that financial year VERGEL recorded revenue of € 185,657 and equity of € 979,732. Compared with financial year 2024, the result moved from € 8,078 to € 80,264. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Growing

€ 979,732

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 80,264

▲ € 72,186 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 39,979

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 849,732.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 8,173

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 39 days on average.

Taxes

€ 19,394

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2023202420242025Change 2024 → 2025
Revenue - - € 64,800 € 185,657 ▲ 187%
Gross margin € -1,428 € 5,545 - -
Profit after taxes € 4,202,623 € 1,996,631 € 8,078 € 80,264 ▲ € 72,186
Equity € 894,759 € 891,390 € 899,468 € 979,732 ▲ 9%
Total debts € 372,188 € 2,420,188 € 473,612 € 566,177 ▲ 20%
Cash € 9,639 € 6,701 € 47,606 € 39,979 ▼ 16%
Land & buildings € 147,870 € 147,870 € 147,870 € 147,870
Retained profit € 764,759 € 761,390 € 769,468 € 849,732 ▲ 10%
Dividend € 4,200,000 € 2,000,000 € 0 € 0
Balance sheet total € 1,266,947 € 3,311,578 € 1,373,080 € 1,545,909 ▲ 13%

Key figures of VERGEL, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VERGEL?

What happened at VERGEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 80,264 (▲ € 72,186 vs 2024). Source: NBB ↗
  • New establishment in Wingene. KBO
  • Start of the company according to the CBE. KBO

In short

From € 4.2 million profit in 2023 to € 80,264 profit in 2025.

Paid € 15,236 in corporate taxes since 2023.

Best year ever: 2023, with € 4.2 million profit.

Paid out € 6.2 million in dividends to the owners in total.

Management

The stake of Bobbie Pharmaceutical Services comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VERGEL
Bofar 100%

Behind VERGEL are Bobbie Pharmaceutical Services BV, Cécile Hoogmartens and CéVéGé BV. The shares are held by Bobbie Pharmaceutical Services (100%). It owns 100% of Bofar itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Bobbie Pharmaceutical Services BV

Managing director · represented by Benoit Devroe (namens Bobbie Company)

Also active at: BOFAR, Farmadistri, FARMAZORG, ULTIMEDI, bmedi, MEDIPACK IMMO

Cécile Hoogmartens

Director

Also active at: BOFAR, Bobbie Company, Bobbie Pharmaceutical Services, ULTIMEDI, bmedi

CéVéGé BV

Director · represented by Verstraete Chris

Also active at: BOFAR, Bobbie Pharmaceutical Services, ULTIMEDI, bmedi

Participations

Bofar

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Flandria 3

8750 Wingene

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0812.259.489
VAT number
BE 0812.259.489
Registered office
Flandria 3, 8750 Wingene
Names & denominations
VERGEL
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
12 June 2009
Peppol
Active · Active since 14 Apr 2026
Activities · NACE

Activiteiten van holdings

Holdings

Frequently asked questions

What does VERGEL do?
VERGEL is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 12 June 2009, 1 establishment.
What is the address of VERGEL?
The registered office of VERGEL is located at Flandria 3, 8750 Wingene.
Is VERGEL still active?
Yes. According to the CBE (28 September 2026) VERGEL is active, legal situation “Normale toestand”, started on 12 June 2009.
Is VERGEL registered on Peppol?
Yes, VERGEL is registered on the Peppol network with ID 0208:0812259489.
What is the enterprise number of VERGEL?
The enterprise number of VERGEL is BE0812259489.
When was VERGEL founded?
VERGEL was founded on 12 June 2009.